English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Ruth de Jauregui
| Jun 4, 2017
National Institute of Health announces promising influenza study tool
Tabitha Fleming
| Jun 2, 2017
European Commission approves dinutuximab beta for treating high-risk neuroblastoma
Ruth de Jauregui
| Jun 2, 2017
Phase III trials of Ofev show positive results for idiopathic pulmonary fibrosis patients
Carrice Quinnie
| Jun 2, 2017
Celgene sees positive results in trial of oral ozanimod for relapsing multiple sclerosis
LocalLabs News Service
| May 31, 2017
K2M Group upgrades surgical device for spinal procedures
Ruth de Jauregui
| May 31, 2017
Boehringer Ingelheim trial shows tiotropium Respimat improves breathing for asthma patients
Ruth de Jauregui
| May 30, 2017
AstraZeneca announces top-line results in EXSCEL Phase IIIb/IV trial of Bydureon in diabetes patients
Robert Hadley
| May 29, 2017
Amgen says Repatha an improvement over standard statin treatment
Trending
Patient Daily
| Jul 8, 2025
Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
Patient Daily
| Jul 9, 2025
FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment
+
Pharmaceuticals
Patient Daily
| Jul 8, 2025
Psychedelic mushrooms' compound shows potential antiaging effects
+
Pharmaceuticals
Patient Daily
| Jul 10, 2025
PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'
« First
«
…
31
32
33
34
35
36
37
…
»
Last »